Lightweight Formula: Absorbs quickly and easily without leaving any residue, making it perfect for daily use and suitable for all skin types
However, FDA has identified serious adverse events associated with CJC-1295 in available data, including increased heart rate and systemic vasodilatory reactions
Injection site reactions: Redness, mild swelling, and occasionally bruising at the injection site
Intended Use This product is supplied strictly for laboratory research purposes only and is intended for use by qualified professionals in controlled scientific environments
These agents pleotropic effects have translated into clinicals trials showing improvement in cardiovascular outcomes, improved quality of life and/or heart failure events in heart failure with preserved ejection fraction, resolution of steatohepatitis and improvement in liver fibrosis, prevention and treatment of type 2 diabetes, and improvement in renal function in chronic kidney disease
10.1002/1873-3468.12989 FEBS Lett